Masimo Current Ratio 2010-2025 | MASI
Current and historical current ratio for Masimo (MASI) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending March 31, 2025 was 2.17.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $1.18B | $0.55B | 2.17 |
| 2024-12-31 | $1.23B | $0.62B | 1.98 |
| 2024-09-30 | $1.28B | $0.64B | 2.01 |
| 2024-06-30 | $1.14B | $0.55B | 2.09 |
| 2024-03-31 | $1.17B | $0.50B | 2.31 |
| 2023-12-31 | $1.23B | $0.56B | 2.19 |
| 2023-09-30 | $1.24B | $0.58B | 2.14 |
| 2023-06-30 | $1.21B | $0.57B | 2.11 |
| 2023-03-31 | $1.26B | $0.58B | 2.16 |
| 2022-12-31 | $1.31B | $0.63B | 2.08 |
| 2022-09-30 | $1.25B | $0.59B | 2.12 |
| 2022-06-30 | $1.16B | $0.55B | 2.10 |
| 2022-03-31 | $1.23B | $0.25B | 4.82 |
| 2021-12-31 | $1.24B | $0.27B | 4.63 |
| 2021-09-30 | $1.14B | $0.23B | 4.99 |
| 2021-06-30 | $1.05B | $0.22B | 4.78 |
| 2021-03-31 | $0.98B | $0.20B | 4.99 |
| 2020-12-31 | $1.10B | $0.23B | 4.71 |
| 2020-09-30 | $1.16B | $0.23B | 4.98 |
| 2020-06-30 | $1.09B | $0.23B | 4.80 |
| 2020-03-31 | $0.98B | $0.16B | 6.23 |
| 2019-12-31 | $1.00B | $0.17B | 5.78 |
| 2019-09-30 | $0.93B | $0.15B | 6.23 |
| 2019-06-30 | $0.86B | $0.14B | 6.35 |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.39 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.767B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.102B | 81.07 |
| Thermo Fisher Scientific (TMO) | United States | $160.563B | 19.42 |
| Edwards Lifesciences (EW) | United States | $45.919B | 30.11 |
| Alcon (ALC) | Switzerland | $43.070B | 29.11 |
| IDEXX Laboratories (IDXX) | United States | $42.738B | 49.12 |
| DexCom (DXCM) | United States | $33.459B | 51.72 |
| IQVIA Holdings (IQV) | United States | $27.702B | 15.52 |
| Mettler-Toledo (MTD) | United States | $24.812B | 29.51 |
| STERIS (STE) | Ireland | $22.211B | 24.46 |
| Waters (WAT) | United States | $18.101B | 25.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.184B | 0.00 |
| Hologic (HOLX) | United States | $14.400B | 15.65 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $9.268B | 72.74 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.953B | 0.00 |
| Teleflex (TFX) | United States | $5.115B | 8.44 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| TransMedics (TMDX) | United States | $3.953B | 85.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.218B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.099B | 24.07 |
| Veracyte (VCYT) | United States | $2.087B | 29.29 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.595B | 0.00 |
| Artivion (AORT) | United States | $1.353B | 126.72 |
| Pulse Biosciences (PLSE) | United States | $1.081B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.738B | 37.47 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.619B | 13.42 |
| Beta Bionics (BBNX) | United States | $0.556B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| AxoGen (AXGN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 10.60 |
| Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.413B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.391B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| RxSight (RXST) | United States | $0.315B | 0.00 |
| NeuroPace (NPCE) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.209B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.20 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 22.22 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |